Myeloproliferative neoplasm primary prevention: Difference between revisions

Jump to navigation Jump to search
Mohamad Alkateb (talk | contribs)
No edit summary
Shyam Patel (talk | contribs)
 
(4 intermediate revisions by 3 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Myeloproliferative disease}}
{{Myeloproliferative disease}}
{{CMG}}{{AE}} {{MJK}}
{{CMG}}{{AE}} {{MJK}} {{shyam}}
==Overview==
==Overview==
There is no established method for prevention of myeloproliferative neoplasm.<ref name="cancergov">National Cancer Institute. Physician Data Query Database 2015.http://www.cancer.gov/types/myeloproliferative</ref>
There is no established method for primary prevention of myeloproliferative neoplasm.
 
==Primary Prevention==
==Primary Prevention==
There is no established method for prevention of myeloproliferative neoplasm.<ref name="cancergov">National Cancer Institute. Physician Data Query Database 2015.http://www.cancer.gov/types/myeloproliferative</ref>
There is no established method for primary prevention of myeloproliferative neoplasm.<ref name="cancergov">National Cancer Institute. Physician Data Query Database 2015.http://www.cancer.gov/types/myeloproliferative</ref> Routine monitoring of the [[complete blood count]] on a yearly basis is sufficient for monitoring.
 
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
Line 13: Line 15:
{{WH}}
{{WH}}
{{WS}}
{{WS}}
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]

Latest revision as of 15:57, 28 June 2018

Myeloproliferative Neoplasm Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating myeloproliferative neoplasm from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Myeloproliferative neoplasm primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Myeloproliferative neoplasm primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Myeloproliferative neoplasm primary prevention

on Myeloproliferative neoplasm primary prevention

Myeloproliferative neoplasm primary prevention in the news

Blogs on Myeloproliferative neoplasm primary prevention

Directions to Hospitals Treating Myeloproliferative neoplasm

Risk calculators and risk factors for Myeloproliferative neoplasm primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2] Shyam Patel [3]

Overview

There is no established method for primary prevention of myeloproliferative neoplasm.

Primary Prevention

There is no established method for primary prevention of myeloproliferative neoplasm.[1] Routine monitoring of the complete blood count on a yearly basis is sufficient for monitoring.

References

  1. National Cancer Institute. Physician Data Query Database 2015.http://www.cancer.gov/types/myeloproliferative

Template:WH Template:WS